Who has invested in TandemAI?

OrbiMed, Chengwei Capital are named among the investors backing TandemAI.

TandemAI Funding: $60M Raised, Series A (2025)

TandemAI funding overview

TandemAI is a Biotech company based in New York City. TandemAI has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2025. The round record for TandemAI runs through 2025; nothing later has been disclosed. Investors on record include OrbiMed, Chengwei Capital. 2 distinct backers are named across the disclosed rounds.

TandemAI at a glance

Total raised: $60M
Latest round: Series A
Latest round date: November 2025
Industry: Biotech
Headquarters: New York City
Notable investors: OrbiMed, Chengwei Capital

Frequently asked about TandemAI funding

How much has TandemAI raised?: TandemAI has raised $60M in total disclosed funding across the rounds on record.
Who has invested in TandemAI?: OrbiMed, Chengwei Capital are named among the investors backing TandemAI.
What was the latest TandemAI funding round?: The most recent disclosed round is a Series A, announced in November 2025.
Where is TandemAI based?: TandemAI is based in New York City.
What sector does TandemAI operate in?: TandemAI is tracked under Biotech from New York City, with $60M in disclosed funding.
When did TandemAI last raise?: The last disclosed TandemAI round closed in November 2025 at Series A.

TandemAI totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in New York City below to benchmark round size and investor mix.

TandemAI Funding: $60M Raised, Series A (2025)

TandemAI funding overview

TandemAI at a glance

Frequently asked about TandemAI funding

TandemAI founders (1)

Companies related to TandemAI (40)

Browse related funding lists (3)